XTSX
BRM
Market cap34mUSD
Jul 10, Last price
3.08CAD
1D
0.66%
1Q
25.00%
Jan 2017
1,170.83%
IPO
-11.59%
Name
Biorem Inc
Chart & Performance
P/E
10.37
P/S
1.18
EPS
0.30
Div Yield, %
—
Shrs. gr., 5y
-13.95%
Rev. gr., 5y
11.68%
Revenues
42m
+13.19%
Net income
5m
+58.25%
CFO
8m
+107.28%
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
BioRem Inc., an engineering firm specializing in clean technology, focuses on the development, production, distribution, and sale of advanced air purification systems. These systems are designed to effectively eliminate unpleasant odors, volatile organic compounds (VOCs), and hazardous air pollutants (HAPs). The company's offerings include biofilters for targeting odors, H2S, VOCs, and HAPs, as well as biotrickling filters specifically tailored for applications involving high concentrations of H2S or other water-soluble VOCs. Additionally, BioRem Inc. provides multi-stage systems for odor control in various municipal and urban wastewater treatment processes, biogas desulfurization systems, dry scrubber adsorption systems, and specialized cannabis odor mitigation solutions. Its service portfolio encompasses biological process consulting and testing, media sampling and analysis, comprehensive system reviews and inspections, and the supply of replacement media and spare parts. Established in 1990 and headquartered in Puslinch, Canada, the company operates across Canada, the United States, China, and various international markets.
Valuation
Title CAD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||